You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: February 25, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204061

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 204061 describes QUARTETTE, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from three suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the QUARTETTE profile page.

The generic ingredient in QUARTETTE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for 204061
Applicant:Teva Branded Pharm
Ingredient:ethinyl estradiol; levonorgestrel
Suppliers and Packaging for NDA: 204061
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QUARTETTE ethinyl estradiol; levonorgestrel TABLET;ORAL 204061 NDA AUTHORIZED GENERIC Teva Pharmaceuticals USA, Inc. 0093-6031 0093-6031-82 2 POUCH in 1 CARTON (0093-6031-82) > 1 KIT in 1 POUCH (0093-6031-91)
QUARTETTE ethinyl estradiol; levonorgestrel TABLET;ORAL 204061 NDA Teva Women's Health, Inc. 51285-431 51285-431-65 1 POUCH in 1 CARTON (51285-431-65) > 1 KIT in 1 POUCH
Paragraph IV (Patent) Challenges for 204061
Tradename Dosage Ingredient NDA Submissiondate
QUARTETTE TABLET;ORAL ethinyl estradiol; levonorgestrel 204061 2013-07-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A
Approval Date:Mar 28, 2013TE:ABRLD:Yes
Patent:  Start TrialPatent Expiration:Mar 11, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:Oct 7, 2025Product Flag?Substance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.